Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|2|209-219

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.2, 2012-01, pp. : 209-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Managing the Adverse Effects of Interferon- Therapy in Multiple Sclerosis

By Bayas A.   Rieckmann P.  

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 149-159

Adis International

Access to resources Recommend Favorite

Multiple Sclerosis: Current and Future Treatment Options

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 4, 2007-12 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and Adverse Effects of Medications Used in the Treatment of Glaucoma

By Camras C.B.   Toris C.B.   Tamesis R.R.  

Drugs & Aging, Vol. 15, Iss. 5, 1999-11 ,pp. : 377-388

Adis International

Access to resources Recommend Favorite

Health-Related Quality of Life in Multiple Sclerosis: Current Evidence, Measurement and Effects of Disease Severity and Treatment

By Rudick Richard A.   Miller Deborah M.  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 827-839

Adis International

Access to resources Recommend Favorite

Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

By Barnes Michael Philip  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 607-615

Informa Healthcare

Access to resources Recommend Favorite